PALB2 and ovarian carcinoma: This variant, first reported in a Swedish ovarian cancer patient with a family history of breast cancer and other malignancies [29], lies on the BRCA1 coiled-coil domain and was reported to disrupt the interaction between BRCA1 and PALB2 [30].